The impact of confirmation bias awareness on mitigating susceptibility to misinformation.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 09 04 2024
accepted: 26 09 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

In the current digital age, the proliferation of misinformation presents a formidable challenge to a democratic society. False narratives surrounding vaccination efforts pose a significant public health risk. Understanding the role of cognitive biases in susceptibility to misinformation is crucial in addressing this challenge. Confirmation bias, characterized by the tendency to favor information that aligns with pre-existing beliefs or attitudes, can exacerbate the spread of false narratives. This study investigates the effect of confirmation bias awareness on susceptibility to general misinformation. For this, a sample of 1,479 participants was recruited, ensuring diverse representation across attitudes towards vaccination. Half of the participants received targeted information about confirmation bias, aimed at increasing awareness of this bias and its potential impact on cognitive processing of information. The other half did not receive this information. Results from the study indicated that participants exposed to an intervention aimed at inducing awareness of confirmation bias demonstrated reduced susceptibility to misinformation and increased ability to general discernment of veracity. Notably, these effects were only pronounced among individuals who initially were most negative towards COVID-19 vaccines. These insights provide a foundation for developing targeted strategies to promote informed decision-making and mitigate the spread of misinformation, particularly in the context of public health crises. Further research is warranted to explore the underlying mechanisms driving these effects and to refine intervention approaches for diverse populations and contexts.

Identifiants

pubmed: 39473590
doi: 10.3389/fpubh.2024.1414864
pmc: PMC11518834
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1414864

Informations de copyright

Copyright © 2024 Piksa, Noworyta, Gundersen, Kunst, Morzy, Piasecki and Rygula.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Références

Trends Cogn Sci. 2018 Mar;22(3):213-224
pubmed: 29475636
Z Gesundh Wiss. 2021 Oct 09;:1-10
pubmed: 34660175
Trends Cogn Sci. 2021 May;25(5):388-402
pubmed: 33736957
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
J Anxiety Disord. 2014 Aug;28(6):570-9
pubmed: 24983798
Nat Commun. 2022 Apr 28;13(1):2333
pubmed: 35484277
BMJ. 2019 Jan 23;364:l365
pubmed: 30674463
Behav Res Methods. 2024 Mar;56(3):1863-1899
pubmed: 37382812
Science. 1974 Sep 27;185(4157):1124-31
pubmed: 17835457
J Pers. 2020 Apr;88(2):185-200
pubmed: 30929263
R Soc Open Sci. 2017 Mar 1;4(3):160802
pubmed: 28405366
Front Psychiatry. 2023 Aug 16;14:1165103
pubmed: 37654985
Nature. 2021 Apr;592(7855):590-595
pubmed: 33731933
Front Psychiatry. 2023 Jan 05;13:974782
pubmed: 36684016
Acad Med. 1995 Aug;70(8):661
pubmed: 7646736
Front Big Data. 2019 Jun 06;2:11
pubmed: 33693334
Cognition. 2019 Jul;188:39-50
pubmed: 29935897
Health Commun. 2023 Oct;38(10):2210-2220
pubmed: 35414311
J Exp Psychol Gen. 2020 Aug;149(8):1608-1613
pubmed: 31916834
Health Secur. 2021 Jan-Feb;19(1):3-12
pubmed: 33090030

Auteurs

Michal Piksa (M)

Affective Cognitive Neuroscience Laboratory, Maj Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland.

Karolina Noworyta (K)

Affective Cognitive Neuroscience Laboratory, Maj Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland.

Aleksander Gundersen (A)

Department of Psychology, University of Oslo, Oslo, Norway.

Jonas Kunst (J)

Department of Psychology, University of Oslo, Oslo, Norway.

Mikolaj Morzy (M)

Faculty of Computing and Telecommunications, Poznan University of Technology, Poznan, Poland.

Jan Piasecki (J)

Department of Philosophy and Bioethics, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.

Rafal Rygula (R)

Affective Cognitive Neuroscience Laboratory, Maj Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH